GlobeNewswire

Acron Group’s Commercial Output Up 3% in H1 2020

Share

17 July 2020

Acron Group’s Commercial Output Up 3% in H1 2020

Group’s consolidated output (including operating results for Acron, Dorogobuzh and North-Western Phosphorous Company)

Product, ‘000 t6M 20206M 2019YOY, %
MINERAL FERTILISERS
Ammonia1,3741,3620.9
Incl. in-house consumption1,3061,189
Nitrogen fertilisers, including2,4422,561-4.7
Incl. in-house consumption403577
AN1,2271,07214.4
Incl. in-house consumption135219
Urea568631-10.1
Incl. in-house consumption269358
UAN648858-24.5
Complex fertilisers, including1,1401,0568.0
Incl. in-house consumption1615
NPK1,0809988.2
Incl. in-house consumption1615
Bulk blends60583.7
Total commercial output for Mineral Fertilisers3,2313,1971.1
INDUSTRIAL PRODUCTS
Organic compounds, including187242-22.7
Incl. in-house consumption94125
Methanol4451-13.6
Incl. in-house consumption3545
Formalin6787-22.8
Incl. in-house consumption5879
Urea-formaldehyde resins75104-27.2
Incl. in-house consumption11
Non-organic compounds, including:49339923.5
Low-density and technical-grade AN1569367.2
Industrial urea666010.6
Calcium carbonate24321711.8
Liquid carbon dioxide2425-2.6
Argon34-4.5
Total commercial output for Industrial Products58551613.4

PHOSPHATE INPUTS
Apatite concentrate53848211.5
Incl. in-house consumption433393
Total commercial output for Apatite Concentrate1059017.2
TOTAL COMMERCIAL OUTPUT3,9213,8033.1

Note: Commercial output is output less in-house consumption

Comments from Alexander Popov, Chairman of Acron’s Board of Directors:

“In H1 2020, Acron Group beat its previous record for commercial output. In the reporting period, the Group produced 3,921,000 tonnes of commercial products up 3% year-on-year. Mineral fertiliser output was up 1% to 3,231,000 tonnes.

“Ammonia output increased 1% to 1,374,000 tonnes, and ammonia processed into finished products went up 10% to a record 1,306,000 tonnes. We plan to further increase our ammonia output by the end of 2020 by upgrading the Ammonia-4 unit, which will expand its capacity to 900,000 tonnes per annum. In the reporting period, agricultural-grade AN output was up 14% to 1,227,000 tonnes. Technical-grade AN output increased 67% to 156,000 tonnes, driven by the Group’s efforts to promote this niche product.

“UAN output was down 25% to 648,000 tonnes, and this reflects the pricing environment, which varied by quarter. Prices were low in Q1 2020, so we dialled back UAN output to 265,000 tonnes. However, in Q2 2020, UAN prices went up due to strong demand and we reacted by increasing UAN output to 383,000 tonnes, which is close to our maximum.

“In May 2020, the Acron facility in Veliky Novgorod launched a new granulated urea unit, improving production chain flexibility and introducing a new product, granulated urea. Since the unit’s commissioning, Acron has produced 34,000 tonnes of granulated urea.

“NPK output was up 8% to 1,140,000 tonnes in response to strong demand and stable supplies of phosphate feedstock – apatite concentrate – from the Group’s Oleniy Ruchey mine. In the reporting period, apatite concentrate output was up 12% to 538,000 tonnes”.

Market Trends

In Q2 2020, global urea prices dropped as expected for the low-demand season. Prices found support in early June 2020, however, and industry experts expect a smooth recovery in the coming months due to strong demand in India and Brazil. The market environment will further improve when demand heats up in Q4 2020 in the Northern Hemisphere.

Urea prices are a benchmark for other nitrogen fertilisers, and AN prices followed that benchmark down in Q2 2020. UAN prices, on the contrary, were up, supported by strong demand in the United States, a key market for this product.

In Q2 2020, NPK prices remained relatively stable, supported by a similar pricing trend for the basic product basket. The prices remained flat in the phosphate segment, and a decrease in the nitrogen segment was offset by a price recovery in the potash segment.

Average Indicative Prices, USD/t, FOB Baltic/Black Sea

Q2
2020
Q1
2020
Q2
2019
Q2 2020 /
Q1 2020

change
Q2 2020 /
Q2 2019

change
NPK 16-16-162582523052.4%-15.3%
AN153187197-18.6%-22.5%
UAN14412313817.2%4.8%
Urea207217250-4.7%-17.3%
Ammonia197222223-11.4%-11.9%



Media Contacts:

Sergey Dorofeev
Anastasia Gromova
Tatiana Smirnova
Public Relations
Phone: +7 (495) 777-08-65 (ext. 5196)

Investor Contacts:

Ilya Popov
Investor Relations
Phone: +7 (495) 745-77-45 (ext. 5252)

Background Information

Acron Group is a leading vertically integrated mineral fertiliser producer in Russia and globally, with chemical production facilities in Veliky Novgorod (Acron) and the Smolensk region (Dorogobuzh). The Group owns and operates a phosphate mine in Murmansk region (North-Western Phosphorous Company, NWPC) and is implementing a potash development project in Perm Krai (Verkhnekamsk Potash Company, VPC). It has a wholly owned transportation and logistics infrastructure, including three Baltic seaport terminals and distribution networks in Russia and China. Acron’s subsidiary, North Atlantic Potash Inc. (NAP), holds mining leases and an exploration permit for ten parcels of the potassium salt deposit at Prairie Evaporite, Saskatchewan, Canada. Acron also holds a minority stake (19.8%) in Polish Grupa Azoty S.A., one of the largest chemical producers in Europe.

In 2019, the Group sold 7.6 million tonnes of main products to 78 countries, with Russia, Brazil, Europe and the United States as key markets.

In 2019, the Group posted consolidated IFRS revenue of RUB 114,835 million (USD 1,774 million) and net profit of RUB 24,786 million (USD 383 million). Acron’s shares are on the Level 1 quotation list of the Moscow Exchange and its global depositary receipts are traded at the London Stock Exchange (ticker AKRN). Acron employs around 11,000 people.

For more information about Acron Group, please visit www.acron.ru/en.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme21.9.2020 10:00:00 CESTPress release

Company Announcement No. 28/2020 Copenhagen, 21 September 2020 Transactions in connection with share buy-back programme On 28 August 2020, Scandinavian Tobacco Group A/S (“STG”) announced that a share buy-back programme of an aggregated price of up to DKK 300 million was launched with the purpose to adjust the Company’s capital structure and meet obligations relating to the Group’s share-based incentive programme. The buy-back programme is executed in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. The share buy-back programme will end no later than 26 February 2021. The following transactions have been executed from 14 September to 18 September 2020: Number of sharesAverage purchase price, DKKTransaction value, DKK Accumulated, last announcement 283,320 28,190,854 14 September 2020 25,000 94.39 2,359,713 15 Sept

Scandinavian Tobacco Group A/S: Transaktioner i forbindelse med aktietilbagekøbsprogram21.9.2020 10:00:00 CESTpressemeddelelse

Selskabsmeddelelse Nr. 28/2020 København, 21. september 2020 Transaktioner i forbindelse med aktietilbagekøbsprogram Den 28. august 2020 informerede Scandinavian Tobacco Group A/S (“STG”) om iværksættelsen af et aktietilbagekøbsprogram til en samlet pris på op til DKK 300 millioner med det formål at justere selskabets kapitalstruktur og opfylde forpligtelserne i forhold til koncernens aktiebaserede incitamentsprogram. Aktietilbagekøbsprogrammet vil blive gennemført i overensstemmelse med EU-forordning nr. 596/2014 af 16. april 2014 (Markedsmisbrugsforordningen) og Kommissionens delegerede forordning (EU) 2016/1052, de såkaldte Safe Harbour-regler. Aktietilbagekøbsprogrammet slutter senest den 26. februar 2021. Følgende transaktioner er foretaget i perioden 14. september - 18. september 2020: Antal aktierGennemsnitlig købspris, DKKTransaktionsværdi, DKK Total, seneste opgørelse 283.320 28.190.854 14. september 2020 25.000 94.39 2.359.713 15. september 2020 25.000 94.50 2.362.538 16. sep

Press Release Oncology Venture Plans Name Change to Allarity Therapeutics and Board Restructuring to Align with Current Company Strategy21.9.2020 09:36:27 CESTPress release

Hørsholm, Denmark (21 September 2020) – Oncology Venture A/S (“OV”) today announced that it will change its company name to Allarity Therapeutics (“Allarity” or the “Company”) and will significantly restructure its Board of Directors to align with the company’s current and long-term strategy. Both the proposed name change and appointment of new Board members are subject to approval of shareholders at the upcoming Extraordinary General Meeting (EGM) planned to be convened on 7 October 2020. Following the proposed restructuring, Allarity’s Board of Directors will comprise five members, including existing Directors Mr. Steve Carchedi (CEO), Mr. Duncan Moore (Chairman), and Dr. Magnus Persson, and new members in both the U.S. and Scandinavia, including Mr. Søren Gade (a current member of European Parliament and former Minister of Defense in Denmark) and Ms. Gail Maderis (current CEO of Antiva Biosciences, Inc., Board member of Valitor, Inc., and former CEO of Five Prime Therapeutics, Inc.)

Immunicum AB: Invitation to Corporate Update Event21.9.2020 08:50:00 CESTPress release

Press Release 21 September 2020 Immunicum AB: Invitation to Corporate Update Event Immunicum AB (publ: IMMU.ST) announced today that the Company will hold a corporate update event and live webcast on September 30, 2020. Investors, media and the public are welcome to join. During the event, CEO, Sven Rohmann, COO, Sijme Zeilemaker and CSO, Alex Karlsson-Parra will present an overview of Immunicum and its development priorities. Corporate Update Event Information Date: Wednesday, September 30, 2020 Time: 18.00 – 19.30 CEST The event will be livestreamed and will remain accessible in video format following the completion of the event. The link to the livestream is available here: https://www.redeye.se/events/793598/live-strategy-update-immunicum Questions can be asked prior to the event by sending an e-mail to ir@immunicum.com or through the video chat during the webcast. Preliminary Agenda: 18:00 – 18:15 Welcome 18:15 – 18:30 The exciting potential of ilixadencel and beyond 18:30 – 18:45

Immunicum AB: inbjudan till företagspresentation21.9.2020 08:50:00 CESTPressemelding

Pressmeddelande 21 september 2020 Immunicum AB: inbjudan till företagspresentation Immunicum AB (publ; IMMU.ST) meddelar idag att företaget kommer att hålla en livesänd företagspresentation den 30 september 2020. Investerare, media och allmänheten välkomnas att delta. Under evenemanget kommer VD Sven Rohmann, COO Sijme Zeilemaker och forskningschef Alex Karlsson-Parra att presentera en bolagsöversikt och prioriteringar för bolagets fortsatta utveckling. Information om företagspresentationen Datum: onsdagen den 30 september 2020 Tid: 18.00 - 19.30 CET Presentationen kommer att webbsändas och kommer även att finnas tillgänglig i efterhand. Länken till webbsändningen finns här: https://www.redeye.se/events/793598/live-strategy-update-immunicum Frågor kan ställas före evenemanget genom att skicka ett e-postmeddelande till ir@immunicum.com eller via videochatten under webbsändningen. Preliminär agenda: 18:00 - 18:15 Välkomnande 18:15 - 18:30 Ilixadencels potential och framtid 18:30 - 18:45

Participation Notification by Blackrock Inc.21.9.2020 08:30:00 CESTPress release

Participation notification by Blackrock Inc. Brussels, September 21, 2020, 08:30 CEST - According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) recently sent to Solvay the following transparency notifications indicating that it crossed the threshold of 3%. Here is a summary of the moves: Date on which the threshold was crossedVoting rights after the transactionEquivalent financial instruments after the transactionTotalSeptember 15, 20203.05%0.11%3.16%September 17, 20202.88%0.16%3.14% The latest notification, dated September 18, 2020, contains the following information: Reason for the notification: acquisition or disposal of voting securities or voting rightsNotified by: BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.)Date on which the threshold is crossed: September 17, 2020Threshold of direct voting rights crossed: 3% downwardsDenominator: 105,876,416Additional information: The disclosure ob